Viewing nowCombinationDualstar Tablet 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.

MFDS item code 201605766 · Approved 2016.09.30 · Insurance code 643704370
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
This medication is used to effectively lower blood pressure and assist in the management of hypertension in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or telmisartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine at 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients who should use this medicine with caution.’) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication is contraindicated in patients with certain conditions, such as those with severely impaired liver function, severe hypotension, cardiogenic shock, and unstable heart failure after acute myocardial infarction. Patients with primary hyperaldosteronism or aortic stenosis and hypertrophic obstructive cardiomyopathy should use this medication cautiously, and patients with liver disease require dosage adjustments and careful monitoring. Patients with gastrointestinal disorders may experience gastrointestinal bleeding or adverse reactions when taking this medication, so caution is advised. Patients with renal artery hypertension, dialysis patients, and the elderly also require special attention when taking this medication. Side effects such as dizziness or peripheral edema may frequently occur during treatment, and more serious side effects like syncope or myocardial infarction may occur infrequently. If symptoms of hypotension develop due to excessively low blood pressure, appropriate action must be taken according to a physician's instructions. This medication may cause hyperkalemia; therefore, regular monitoring of serum potassium levels is necessary, and caution is advised when taken with potassium-sparing medications or potassium-rich foods. Additionally, this medication may affect renal function, so patients with impaired kidney function should monitor their renal status regularly through blood tests. This medication may interact with other antihypertensives or drugs, so if other medications are being taken, the physician or pharmacist should be informed. In particular, taking this medication with grapefruit juice may excessively increase its effects, so it is recommended to avoid this combination. Pregnant and breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, treatment should be discontinued immediately. Safety and efficacy have not been adequately established for children and adolescents, so use in this population is not recommended. Caution is required when driving or operating hazardous machinery, as dizziness or drowsiness may occur during treatment. In case of overdose, symptoms such as hypotension, arrhythmia, or acute renal failure may occur, and immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects against light. It should be stored at a safe room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
A biconvex oval double tablet that is white and light gray in color.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.